ZIMMER BIOMET HOLDINGS, INC.
ZIMMER BIOMET HOLDINGS, INC.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 424 | 592 | 1,293 | 557 | 1,385 | 526 | 569 | 420 | 393 | 416 | 292 | 320 | |||||
Accounts Receivable Net Current | 1,729 | 1,704 | 1,598 | 1,611 | 1,533 | 1,481 | 1,482 | 1,418 | 1,446 | 1,442 | 1,341 | 1,367 | |||||
Inventory Net | 2,247 | 2,286 | 2,484 | 2,454 | 2,244 | 2,235 | 2,369 | 2,370 | 2,388 | 2,385 | 2,323 | 2,276 | |||||
Prepaid Expense And Other Assets Current | 563 | 537 | 460 | 431 | 428 | 430 | 445 | 431 | 404 | 366 | 416 | 425 | |||||
Assets Current | 4,963 | 5,120 | 5,835 | 5,054 | 5,590 | 4,672 | 4,864 | 4,639 | 4,632 | 4,610 | 4,372 | 4,388 | |||||
Property Plant And Equipment Net | 2,212 | 2,207 | 2,194 | 2,176 | 2,065 | 2,049 | 2,107 | 2,103 | 2,091 | 2,060 | 2,032 | 1,975 | |||||
Goodwill | 9,932 | 9,947 | 9,702 | 9,710 | 8,989 | 8,951 | 8,912 | 8,825 | 8,792 | 8,819 | 8,710 | 8,744 | |||||
Intangible Assets Net Excluding Goodwill | 4,548 | 4,717 | 4,740 | 4,891 | 4,468 | 4,598 | 4,665 | 4,707 | 4,734 | 4,856 | 4,892 | 5,028 | |||||
Other Assets Noncurrent | 1,068 | 1,100 | 1,017 | 1,035 | 1,072 | 1,096 | 1,172 | 1,246 | 1,204 | 1,152 | 1,211 | 1,160 | |||||
Assets | 22,722 | 23,092 | 23,488 | 22,865 | 22,184 | 21,365 | 21,720 | 21,520 | 21,452 | 21,497 | 21,217 | 21,294 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 361 | 303 | 315 | 349 | 301 | 195 | 322 | 342 | 370 | 411 | 320 | 355 | |||||
Accrued Income Taxes Current | - | - | - | - | - | - | - | - | 70 | 61 | 97 | 82 | |||||
Employee Related Liabilities Current | 294 | - | - | - | - | - | - | - | - | - | - | - | |||||
Other Liabilities Current | 1,033 | 1,694 | 1,488 | 1,531 | 1,394 | 1,393 | 1,536 | 1,389 | 1,386 | 1,547 | 1,300 | 1,278 | |||||
Long Term Debt Current | 1,176 | 587 | 600 | 820 | 600 | 863 | 1,713 | 1,878 | 970 | 900 | 355 | 520 | |||||
Liabilities Current | 2,864 | 2,584 | 2,403 | 2,700 | 2,295 | 2,451 | 3,571 | 3,608 | 2,797 | 2,857 | 2,072 | 2,234 | |||||
Deferred Income Tax Liabilities Net | 250 | 244 | - | - | - | 353 | - | - | 370 | 358 | 465 | 475 | |||||
Accrued Income Taxes Noncurrent | - | - | - | - | - | - | - | - | 276 | 274 | 403 | 376 | |||||
Other Liabilities Noncurrent | 631 | 626 | 806 | 879 | 909 | 744 | 1,028 | 1,205 | 577 | 926 | 632 | 642 | |||||
Long Term Debt Noncurrent | 6,295 | 6,932 | 7,513 | 6,753 | 6,576 | 5,342 | 4,738 | 3,957 | 4,826 | 4,868 | 5,127 | 5,189 | |||||
Liabilities | 10,040 | 10,386 | 10,722 | 10,331 | 9,780 | 8,889 | 9,337 | 8,771 | 8,846 | 9,009 | 8,699 | 8,916 | |||||
Common Stock Value | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | |||||
Additional Paid In Capital Common Stock | 10,199 | 10,179 | 10,156 | 10,108 | 10,087 | 10,038 | 10,018 | 9,975 | 9,946 | 9,846 | 9,801 | 9,766 | |||||
Retained Earnings Accumulated Deficit | 11,803 | 11,611 | 11,519 | 11,335 | 11,230 | 11,095 | 10,904 | 10,703 | 10,509 | 10,385 | 10,015 | 9,902 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -190 | -206 | -284 | -285 | -287 | -263 | -202 | -195 | -211 | -191 | -187 | -178 | |||||
Treasury Stock Value | -9,141 | -8,889 | -8,637 | -8,637 | -8,637 | -8,406 | -8,348 | -7,744 | -7,649 | -7,562 | -7,122 | -7,122 | |||||
Stockholders Equity | 12,673 | 12,706 | 12,766 | 12,525 | 12,395 | 12,476 | 12,375 | 12,749 | 12,606 | 12,488 | 12,511 | 12,379 | |||||
Minority Interest | 8 | 8 | 10 | 9 | 9 | 8 | 9 | 8 | 8 | 8 | 7 | 7 | |||||
Liabilities And Stockholders Equity | 22,722 | 23,092 | 23,488 | 22,865 | 22,184 | 21,365 | 21,720 | 21,520 | 21,452 | 21,497 | 21,217 | 21,294 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | |||||
Common Stock Shares Issued | 319 | 319 | 319 | 318 | 318 | 318 | 317 | 317 | 317 | 316 | 316 | 316 | |||||
Treasury Stock Common Shares | 126 | 123 | 121 | 121 | 121 | 118 | 118 | 112 | 112 | 111 | 107 | 107 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 3.14% | 6.12% | 10.21% | - | - | - | - | - | - | - | - | - |
| 2025 | 1.87% | 1.35% | 8.09% | 7.79% | -0.19% | 4.93% | 11.39% | 3.68% | -0.82% | -5.62% | -5.45% | -16.40% |
| 2024 | -1.73% | -8.95% | -6.51% | 9.12% | 2.28% | -3.06% | 0.37% | -2.45% | 0.00% | 3.15% | -8.59% | -9.49% |
| 2023 | -10.74% | 0.85% | -0.38% | -12.88% | -11.66% | -20.78% | 11.37% | 15.12% | 15.11% | -3.10% | -3.46% | -5.92% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 1.73 | 1.98 | 2.43 | 1.87 | 2.44 | 1.91 | 1.36 | 1.29 | 1.66 | 1.61 | 2.11 | 1.96 | |||||
| Quick Ratio | 0.75 | 0.89 | 1.20 | 0.80 | 1.27 | 0.82 | 0.57 | 0.51 | 0.66 | 0.65 | 0.79 | 0.76 | |||||
| Working Capital | 2.10B | 2.54B | 3.43B | 2.35B | 3.30B | 2.22B | 1.29B | 1.03B | 1.83B | 1.75B | 2.30B | 2.15B | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.79 | 0.82 | 0.84 | 0.82 | 0.79 | 0.71 | 0.75 | 0.69 | 0.70 | 0.72 | 0.70 | 0.72 | |||||
| Interest Coverage TTM | 3.99 | 3.75 | 4.71 | 4.82 | 5.62 | 5.90 | 6.06 | 6.09 | 5.97 | 6.35 | 4.63 | 4.73 | |||||
| Debt Ratio | 0.44 | 0.45 | 0.46 | 0.45 | 0.44 | 0.42 | 0.43 | 0.41 | 0.41 | 0.42 | 0.41 | 0.42 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.37 | 0.37 | 0.35 | 0.35 | 0.35 | 0.36 | 0.35 | 0.35 | 0.35 | 0.35 | 0.34 | 0.34 | |||||
| Days Sales Outstanding TTM | 70.79 | 70.62 | 70.16 | 70.57 | 70.64 | 69.47 | 67.81 | 67.55 | 69.24 | 69.70 | 65.67 | 67.20 | |||||
| Receivables Turnover TTM | 5.16 | 5.17 | 5.20 | 5.17 | 5.17 | 5.25 | 5.38 | 5.40 | 5.27 | 5.24 | 5.56 | 5.43 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 3.89 | 3.55 | 4.05 | 4.15 | 4.57 | 4.43 | 5.34 | 4.83 | 4.68 | 4.88 | 2.26 | 2.41 | |||||
| Free Cash Flow Per Share TTM | 7.47 | 7.44 | 7.50 | 7.44 | 7.34 | 6.38 | 6.75 | 6.17 | 5.86 | 6.18 | 4.53 | 5.25 | |||||
| Dividend Per Share TTM | 0.97 | 0.96 | 0.96 | 0.97 | 0.98 | 0.97 | 0.98 | 0.97 | 0.97 | 0.96 | 0.96 | 0.97 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 70.03% | 69.71% | 71.44% | 71.06% | 71.05% | 71.46% | 71.78% | 71.78% | 71.88% | 71.82% | 71.63% | 71.72% | |||||
| Operating Profit Margin TTM | 14.02% | 13.34% | 16.63% | 16.09% | 17.04% | 16.74% | 16.47% | 16.45% | 16.32% | 17.28% | 12.30% | 12.15% | |||||
| Net Profit Margin TTM | 9.05% | 8.57% | 10.05% | 10.51% | 11.86% | 11.77% | 14.27% | 13.25% | 12.94% | 13.85% | 6.52% | 7.03% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 9.23% | 7.20% | 5.47% | 4.11% | 3.30% | 3.85% | 4.34% | 4.58% | 4.85% | 6.55% | 5.62% | 4.17% | |||||
| Net Income Growth (1Y) | -16.63% | -21.98% | -25.73% | -17.47% | -5.29% | -11.74% | 128.32% | 97.11% | 114.22% | 342.52% | 71.15% | 121.01% | |||||
| EPS Growth (1Y) | -14.96% | -19.98% | -24.15% | -14.22% | -2.29% | -9.30% | 135.77% | 99.89% | 118.61% | 344.43% | 71.89% | 122.07% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 23.10 | 25.12 | 24.05 | 21.70 | 24.34 | 23.38 | 19.80 | 21.95 | 27.49 | 24.22 | 48.14 | 58.38 | |||||
| P/B TTM | 1.39 | 1.39 | 1.52 | 1.43 | 1.79 | 1.69 | 1.73 | 1.72 | 2.10 | 1.99 | 1.83 | 2.39 | |||||
| P/S TTM | 2.09 | 2.15 | 2.42 | 2.28 | 2.89 | 2.75 | 2.83 | 2.91 | 3.56 | 3.35 | 3.14 | 4.10 | |||||
| Market Cap | 17.59B | 17.71B | 19.36B | 17.86B | 22.22B | 21.13B | 21.46B | 21.89B | 26.50B | 24.80B | 22.85B | 29.54B | |||||
| Enterprise Value | 24.63B | 24.64B | 26.18B | 24.88B | 28.01B | 26.81B | 27.34B | 27.30B | 31.90B | 30.15B | 28.04B | 34.93B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 1.46B | 1.47B | 1.48B | 1.47B | 1.46B | 1.30B | 1.37B | 1.27B | 1.20B | 1.29B | 945.70M | 1.10B | |||||
| Net Debt | 7.05B | 6.93B | 6.82B | 7.02B | 5.79B | 5.68B | 5.88B | 5.41B | 5.40B | 5.35B | 5.19B | 5.39B | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
ZIMMER BIOMET HOLDINGS, INC. (ZBH) — SEC Financial Statements & Analysis
ZIMMER BIOMET HOLDINGS, INC. (ZBH) is a orthopedic, prosthetic & surgical appliances & supplies company, incorporated in DE. ZIMMER BIOMET HOLDINGS, INC. trades on ZBH: NYSE as: ZBH. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), ZIMMER BIOMET HOLDINGS, INC. reported a 9.23% year-over-year revenue growth, a Gross Profit Margin of 70.03% (TTM), a Debt-to-Equity ratio of 0.79x, a Price-to-Sales (P/S) ratio of 2.09x (TTM), a Price-to-Book (P/B) ratio of 1.39 (TTM), at a market cap of $17.59B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 9.23%
- Gross Profit Margin TTM
- 70.03%
- Debt To Equity
- 0.79x
- P/S TTM
- 2.09x
- P/B TTM
- 1.39
- Market Cap
- $17.59B
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is ZIMMER BIOMET HOLDINGS, INC. in?
ZIMMER BIOMET HOLDINGS, INC. (ZBH) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry.
What is ZBH's market cap?
ZIMMER BIOMET HOLDINGS, INC. (ZBH) has a market capitalization of $17.59B as of 2026-03-31.
What is ZBH's P/E ratio?
ZIMMER BIOMET HOLDINGS, INC. (ZBH)'s trailing twelve month P/E ratio is 23.10x as of 2026-03-31.
What exchange does ZBH trade on?
ZIMMER BIOMET HOLDINGS, INC. (ZBH) trades on the ZBH: NYSE.
Where is ZIMMER BIOMET HOLDINGS, INC. incorporated?
ZIMMER BIOMET HOLDINGS, INC. is incorporated in DE.